Skip Navigation LinksHome > September/October 2013 - Volume 5 - Issue 5 > Neuromodulators—Between the Lines
Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0b013e3182a525f0
Feature Articles

Neuromodulators—Between the Lines

Consolmagno, Lynn

Continued Education
Collapse Box

Abstract

ABSTRACT: The frequency of nonsurgical cosmetic procedures, specifically the injection of neuromuscular modulators produced by Clostridium botulinum type A exotoxin, frequently referred to as BoNTA, such as Botox Cosmetic (Allergan), Dysport (Medicis), and Xeomin (Merz), is increasingly common in the war on aging. Although the overall number of cosmetic surgical procedures has decreased, in the past decade, less-invasive injectable treatments have gained popularity. BoNTA agents are the most popular option for reducing or eliminating facial rhytids by causing dynamic muscle relaxation through chemodenervation of facial striated muscles. This article will provide an overview of indications, efficacy, risks, and product choices.

Copyright © 2013 by the Dermatology Nurses' Association.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.